A specific mutation in TBL1XR1 causes Pierpont syndrome. Issue 5 (14th January 2016)

• Record Type: Journal Article
• Authors: Heinen, Charlotte A; Jongejan, Aldo; Watson, Peter J; Redeker, Bert; Boelen, Anita; Boudzovitch-Surovtseva, Olga; Forzano, Francesca; Hordijk, Roel; Kelley, Richard; Olney, Ann H; Pierpont, Mary Ella; Schaefer, G Bradley; Stewart, Fiona; van Trotsenburg, A S Paul; Fliers, Eric; Schwabe, John W R; Hennekam, Raoul C
• Is Part Of: Journal of medical genetics. Volume 53:Issue 5(2016)
• Page Start: 330
• Page End: 337
• Publication Date: 2016-01-14
• Subjects: Genetics -- Molecular genetics -- Psychiatry; Medical genetics -- Periodicals; 616.042
• DOI: 10.1136/jmedgenet-2015-103233
• Languages: English
• ISSNs: 1468-6244

Abstract

Abstract : Background: The combination of developmental delay, facial characteristics, hearing loss and abnormal fat distribution in the distal limbs is known as Pierpont syndrome. The aim of the present study was to detect and study the cause of Pierpont syndrome. Methods: We used whole-exome sequencing to analyse four unrelated individuals with Pierpont syndrome, and Sanger sequencing in two other unrelated affected individuals. Expression of mRNA of the wild-type candidate gene was analysed in human postmortem brain specimens, adipose tissue, muscle and liver. Expression of RNA in lymphocytes in patients and controls was additionally analysed. The variant protein was expressed in, and purified from, HEK293 cells to assess its effect on protein folding and function. Results: We identified a single heterozygous missense variant, c.1337A>C (p.Tyr446Cys), in transducin β-like 1 X-linked receptor 1 ( TBL1XR1 ) as disease-causing in all patients. TBL1XR1 mRNA expression was demonstrated in pituitary, hypothalamus, white and brown adipose tissue, muscle and liver. mRNA expression is lower in lymphocytes of two patients compared with the four controls. The mutant TBL1XR1 protein assembled correctly into the nuclear receptor corepressor (NCoR)/ silencing mediator for retinoid and thyroid receptors (SMRT) complex, suggesting a dominant-negative mechanism. This contrasts with loss-of-function germline TBL1XR1 deletions and other TBL1XR1 mutations that have been implicated in autism. However, autism is not present in individuals with Pierpont syndrome. Conclusions: This study identifies a specific TBL1XR1 mutation as the cause of Pierpont syndrome. Deletions and other mutations in TBL1XR1 can cause autism. The marked differences between Pierpont patients with the p.Tyr446Cys mutation and individuals with other mutations and whole gene deletions indicate a specific, but as yet unknown, disease mechanism of the TBL1XR1 p.Tyr446Cys mutation.